Ambulatory Care Pharmacy Forum of NC Annual Meeting 2022

Share This Event

*Registration payment includes Credit Cards and Interfund Transfers ONLY.

Target Audience

Pharmacists

Description

The Ambulatory Care Pharmacy Forum of North Carolina is a network for and led by ambulatory clinical pharmacists with an ongoing goal of providing networking, collaboration, and educational opportunities for likeminded pharmacists in North Carolina with an emphasis on practical ambulatory care topics and unmet public health needs.

In addition to providing networking opportunities for ambulatory care pharmacist, this application-based CPE activity will provide the pharmacist with clinical practice updates on a variety of topics.

For more information on Ambulatory Care Pharmacy Forum of NC, Click on: www.AmbulatoryCarePharmacyForum.com

Download conference brochure for full description including agenda, objectives and speakers.

This conference will be offered as a live stream webinar.

Live Webinar Information
This webinar will be broadcast with Zoom. Instructions to join the webinar will be emailed prior to the event. Please go to our live webinar requirements page for more information and to test the computer/device and network prior to the event.


Continuing Education Credit For Pharmacists:
The University Of North Carolina Eshelman School Of Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. The program ACPE 0046-9999-22-016-L01-P (Pharmacist) provides 4.0 contact hours of continuing pharmacy education credit. To receive CE credit, you must complete the CE attendance form and the evaluation of the program. Statement of credit can be viewed and printed in CPE Monitor. Statements of CE Credit will be processed in approximately 2 to 3 weeks. **No partial credit will be available**


CONFERENCE AGENDA (please check back for updates in agenda times):

8:00 am – 8:15 am - Welcome, Introductions, Instructions - Pete Koval, PharmD, BCPS, CPP and Josh Guffey, PharmD, BCACP, BC-ADM, BCPS
A Word from the Ambulatory Care Pharmacy Forum Founder - Keith Latham, PharmD

8:15 am – 9:15 am - Defend the Kidney: New Evidence and Pharmacotherapy for Chronic Kidney Disease- Jennifer N. Clements, PharmD, FCCP, FADCES, BCPS, CDCES, BCACP, BC-ADM

9:15 am – 9:30 am BREAK/Breakout room for sponsors


9:30 to 10:30 - Manage Obesity Before the Complications Arise - Shawn Riser Taylor, PharmD, CPP, CDCES

10:30 am – 10:45 am BREAK/ Breakout room for sponsors

10:45 am –11:45am CGM – Continuous Glucose Monitors – Case Application - Erika Peterfy, PharmD, CDCES, BCACP, CPP. Cathey Miller, PharmD, CDE, CPP and Lisa Meade PharmD, CDE


11:45 am to 12:00 PM BREAK/Breakout room for sponsors

12:00 PM to 1:00 PM - Contraceptive Therapy Updates- Rachel Selinger, PharmD, BCACP, CPP, CDCES and Elizabeth Salisbury, PharmD

1:05 PM Wrap Up and Close - Josh Guffey

Thank you to our exhibitors sponsors:
Abbott Diabetes Care
Bayer Pharmaceuticals

Objectives

• Identify renal outcomes and guideline recommendations from historical and recent evidence (CLEMENTS)
• Discuss the literature for existing and new pharmacotherapy for chronic kidney disease (CLEMENTS)
• Select a specific treatment plan, including monitoring parameters, to optimize outcomes for a specific clinical scenario (CLEMENTS)
• Discuss the available pharmacological agents of obesity treatment (RISER TAYLOR)
• Identify evidence to manage obesity and improve outcomes (RISER TAYLOR)
• Describe barriers to incorporating obesity services (RISER TAYLOR)
• Outline best practices for an obesity service in an ambulatory setting (RISER TAYLOR)
• Summarize key counseling points of oral and transdermal contraceptive agents (Selinger/Salisbury)
• Outline clinical pearls for managing contraceptives based on patient preferences and scenarios (Selinger/Salisbury)
• Identify unique properties of available contraceptive formulations (Salenger/Salisbury)
• Describe available continuous glucose monitor devices (PETERFY/MILLER/MEADE)
• Identify key components of continuous glucose monitor reports (PETERFY/MILLER/MEADE)
• Identify appropriate therapy adjustments based on continuous glucose monitor results (PETERFY/MILLER/MEADE)

Sessions